<!DOCTYPE HTML SYSTEM "HTML4.DTD" >
<HTML>
<HEAD>
<TITLE>ICD-10: Block G70-G73
</TITLE>
<LINK HREF="style.css" REL="stylesheet" TYPE="text/css">
<META NAME="AUTHOR" CONTENT="Michael Schopen">
<META NAME="DESCRIPTION" CONTENT="International Statistical Classification of Diseases and Related Health Problems (ICD-10). HTML files for WWW.">
<META NAME="KEYWORDS" CONTENT="ICD-10; tabular list;chapter VI">
<META NAME="COPYRIGHT" CONTENT="WHO">
<META NAME="ROBOTS" CONTENT="index, follow">
<SCRIPT TYPE="text/JavaScript">
  function openSub(URL) {
    var SUB = window.open(URL, "SUB", "dependent=1,height=200,width=500,resizable=1,scrollbars=1") ;
    SUB.focus() ;
  }
</SCRIPT>
<SCRIPT TYPE="text/JavaScript">
function setNavi(url,hash) {
  if (window.name != "SUB") {
    if ((parent.location.href == self.location.href) || (!parent.correct_frame)) {
      window.location.replace('fr-icd.htm?'+url+'+'+hash) ;
    }
    else {
      with (parent.navi.document) {
        open('text/html','replace') ;
        writeln('<HEAD>') ;
        writeln('<TITLE>Navigational frame work ICD-10</TITLE>') ;
        writeln('<link href="style.css" rel="stylesheet" type="text/css">') ;
        writeln('</HEAD>') ;
        writeln('<BODY BGCOLOR="#000080">') ;
        writeln('<table border="0" cellpadding="4" cellspacing="4" width="100%">') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="navi.htm#ka00">List&nbsp;of&nbsp;Chapters</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="kg00.htm">Chapter&nbsp;Introduction</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="kg00.htm#glied">List&nbsp;of&nbsp;Blocks</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="gg60.htm">Previous&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="gg80.htm">Next&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td>&nbsp;</td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="_top" HREF="http://www.who.int/classifications/icd">ICD Homepage</A></td></tr></table>') ;
        close() ;
      }
    }
  }
}
</SCRIPT>

</HEAD>

<BODY BGCOLOR="#FFFFFF" onLoad="setNavi('gg70.htm',window.location.hash.substring(1))">

<H1>Chapter VI
<BR>
<HR>Diseases of the nervous system
<BR>(G00-G99)
</H1>
<H2>Diseases of myoneural junction and muscle
<BR>(G70-G73)
</H2>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="g70">
</A>G70
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myasthenia gravis and other myoneural disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">botulism 
<NOBR>(
<A HREF="ga00.htm#a051">A05.1
</A>)
</NOBR>
<BR>transient neonatal myasthenia gravis 
<NOBR>(
<A HREF="gp90.htm#p940">P94.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g700">
</A>G70.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myasthenia gravis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g701">
</A>G70.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Toxic myoneural disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify toxic agent.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g702">
</A>G70.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Congenital and developmental myasthenia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g708">
</A>G70.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified myoneural disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g709">
</A>G70.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myoneural disorder, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="g71">
</A>G71
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Primary disorders of muscles
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">arthrogryposis multiplex congenita 
<NOBR>(
<A HREF="gq65.htm#q743">Q74.3
</A>)
</NOBR>
<BR>metabolic disorders 
<NOBR>(
<A HREF="ge70.htm#e70">E70-E90
</A>)
</NOBR>
<BR>myositis 
<NOBR>(
<A HREF="gm60.htm#m60">M60.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g710">
</A>G71.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Muscular dystrophy
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Muscular dystrophy:
<BR>&middot; autosomal recessive, childhood type, resembling Duchenne or Becker
<BR>&middot; benign [Becker]
<BR>&middot; benign scapuloperoneal with early contractures [Emery-Dreifuss]
<BR>&middot; distal
<BR>&middot; facioscapulohumeral
<BR>&middot; limb-girdle
<BR>&middot; ocular
<BR>&middot; oculopharyngeal
<BR>&middot; scapuloperoneal
<BR>&middot; severe [Duchenne]
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">congenital muscular dystrophy:
<BR>&middot; NOS 
<NOBR>(
<A HREF="#g712">G71.2
</A>)
</NOBR>
<BR>&middot; with specific morphological abnormalities of the muscle fibre 
<NOBR>(
<A HREF="#g712">G71.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g711">
</A>G71.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myotonic disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Dystrophia myotonica [Steinert]
<BR>Myotonia:
<BR>&middot; chondrodystrophic
<BR>&middot; drug-induced
<BR>&middot; symptomatic
<BR>Myotonia congenita:
<BR>&middot; NOS
<BR>&middot; dominant [Thomsen]
<BR>&middot; recessive [Becker]
<BR>Neuromyotonia [Isaacs]
<BR>Paramyotonia congenita
<BR>Pseudomyotonia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g712">
</A>G71.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Congenital myopathies
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Congenital muscular dystrophy:
<BR>&middot; NOS
<BR>&middot; with specific morphological abnormalities of the muscle fibre
<BR>Disease:
<BR>&middot; central core
<BR>&middot; minicore
<BR>&middot; multicore
<BR>Fibre-type disproportion
<BR>Myopathy:
<BR>&middot; myotubular (centronuclear)
<BR>&middot; nemaline
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g713">
</A>G71.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mitochondrial myopathy, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g718">
</A>G71.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other primary disorders of muscles
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g719">
</A>G71.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Primary disorder of muscle, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hereditary myopathy NOS
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="g72">
</A>G72
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other myopathies
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">arthrogryposis multiplex congenita 
<NOBR>(
<A HREF="gq65.htm#q743">Q74.3
</A>)
</NOBR>
<BR>dermatopolymyositis 
<NOBR>(
<A HREF="gm30.htm#m33">M33.-
</A>)
</NOBR>
<BR>ischaemic infarction of muscle 
<NOBR>(
<A HREF="gm60.htm#m622">M62.2
</A>)
</NOBR>
<BR>myositis 
<NOBR>(
<A HREF="gm60.htm#m60">M60.-
</A>)
</NOBR>
<BR>polymyositis 
<NOBR>(
<A HREF="gm30.htm#m332">M33.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g720">
</A>G72.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Drug-induced myopathy
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g721">
</A>G72.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Alcoholic myopathy
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g722">
</A>G72.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myopathy due to other toxic agents
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify toxic agent.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g723">
</A>G72.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Periodic paralysis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Periodic paralysis (familial):
<BR>&middot; hyperkalaemic
<BR>&middot; hypokalaemic
<BR>&middot; myotonic
<BR>&middot; normokalaemic
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g724">
</A>G72.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Inflammatory myopathy, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g728">
</A>G72.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified myopathies
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g729">
</A>G72.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myopathy, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="g73">
</A>G73*
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of myoneural junction and muscle in diseases classified elsewhere
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g730">
</A>G73.0*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myasthenic syndromes in endocrine diseases
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Myasthenic syndromes in:
<BR>&middot; diabetic amyotrophy 
<NOBR>(
<A HREF="ge10.htm#e10">E10-E14+
</A> with common fourth character .4)
</NOBR>
<BR>&middot; thyrotoxicosis [hyperthyroidism] 
<NOBR>(
<A HREF="ge00.htm#e05">E05.-+
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g731">
</A>G73.1*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Eaton-Lambert syndrome
</STRONG> 
<NOBR>(
<A HREF="gc76.htm#c80">C80+
</A>)
</NOBR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g732">
</A>G73.2*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other myasthenic syndromes in neoplastic disease
</STRONG> 
<NOBR>(
<A HREF="gc00.htm#c00">C00-D48+
</A>)
</NOBR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g733">
</A>G73.3*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myasthenic syndromes in other diseases classified elsewhere
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g734">
</A>G73.4*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myopathy in infectious and parasitic diseases classified elsewhere
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g735">
</A>G73.5*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myopathy in endocrine diseases
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Myopathy in:
<BR>&middot; hyperparathyroidism 
<NOBR>(
<A HREF="ge20.htm#e210">E21.0-E21.3+
</A>)
</NOBR>
<BR>&middot; hypoparathyroidism 
<NOBR>(
<A HREF="ge20.htm#e20">E20.-+
</A>)
</NOBR>
<BR>Thyrotoxic myopathy 
<NOBR>(
<A HREF="ge00.htm#e05">E05.-+
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g736">
</A>G73.6*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myopathy in metabolic diseases
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Myopathy in:
<BR>&middot; glycogen storage disease 
<NOBR>(
<A HREF="ge70.htm#e740">E74.0+
</A>)
</NOBR>
<BR>&middot; lipid storage disorders 
<NOBR>(
<A HREF="ge70.htm#e75">E75.-+
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="g737">
</A>G73.7*
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Myopathy in other diseases classified elsewhere
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Myopathy in:
<BR>&middot; rheumatoid arthritis 
<NOBR>(
<A HREF="gm05.htm#m05">M05-M06+
</A>)
</NOBR>
<BR>&middot; scleroderma 
<NOBR>(
<A HREF="gm30.htm#m348">M34.8+
</A>)
</NOBR>
<BR>&middot; sicca syndrome [Sj&ouml;gren] 
<NOBR>(
<A HREF="gm30.htm#m350">M35.0+
</A>)
</NOBR>
<BR>&middot; systemic lupus erythematosus 
<NOBR>(
<A HREF="gm30.htm#m321">M32.1+
</A>)
</NOBR>
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<HR>
<TABLE BORDER="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="33%">Processed on 03.06.2003 
<A HREF="mailto:schopen@dimdi.de">M.S.
</A>
</TD>
<TD VALIGN="TOP" ALIGN="CENTER" WIDTH="34%">Source: World Health Organization
</TD>
<TD VALIGN="TOP" ALIGN="RIGHT" WIDTH="33%">&copy; Copyright WHO 1994/2003
</TD>
</TR>
</TABLE>
</BODY >
</HTML>
